7 completed, 5 unknown, 2 recruiting, 2 withdrawn. 7 Phase 4, 6 Not applicable, 4 Phase 3, 2 Phase 2.
Follow ondansetron 4 mg: new trials by email Literature Review of ondansetron 4 mg trials Research Report on ondansetron 4 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy ondansetron 4 mg, Dexamethasone (intravenous), Metoclopramide 10mg - Postoperative Nausea and Vomiting | Phase 4 | Recruiting | Faisalabad Medical University | 264 | 2026-09-01 | 2026-09-04 |
| Antiemetic Fosaprepitant To Remedy Nausea and Vomiting Fosaprepitant 150 mg, Ondansetron 4 mg - Nausea and Vomiting, Nausea | Phase 2 / Phase 3 | Recruiting | Montefiore Medical Center | 200 | 2024-11-13 | 2026-05-18 |
| Effect of Kinesiotape on Emesis in Pregnant Women Antiemetic Drug, Vitamin B6, Home care advice - Emesis Pregnancy | Not applicable | Not yet recruiting | Cairo University | 50 | 2024-10-07 | 2024-10-08 |
| Ondansetron for Postspinal Anesthesia Hypotension normal saline, Ondansetron 4 mg, Ondansetron 8 mg - Adverse Effect | Not applicable | Completed | General Hospital of Ningxia Medical University | 120 | 2023-06-18 | 2023-11-02 |
| Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data Neuraxial Analgesia, Regional Block 1: Paravertebral, Perphenazine - Perioperative Optimization | Phase 3 | Completed | Jennifer Holder-Murray | 3395 | 2023-05-15 | 2026-05-28 |
| Melatonin vs Pregabalin for Anxiolysis and Sedation Melatonin, Pregabalin, Ondansetron 4 MG - Anxiety | Phase 4 | Completed | Menoufia University | 78 | 2022-01-30 | 2022-12-21 |
| Ephedrine Versus Ondansetron During Cesarean Delivery Ondansetron 4 MG, Ondansetron 8mg, EPHEDrine 10 Mg/mL-NaCl 0.9% Intravenous Solution - Spinal Induced Hypotension | Phase 4 | Completed | Ain Shams University | 168 | 2022-01-10 | 2022-09-09 |
| Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial Ondansetron 4 MG - Vomiting in Infants and/or Children | Phase 4 | Unknown | Lizar Aguirre Pascasio | 220 | 2021-10-10 | 2021-04-21 |
| Enhanced Recovery Pathway for Endoscopy Ondansetron 4 MG, Lactated Ringers, Intravenous, Early Mobilization - Enhanced Recovery Pathway, Endoscopy | Phase 4 | Withdrawn | Northwestern University | 2021-09-01 | 2021-12-15 | |
| ONDANSETRON AND EFFECTIVE DOSE IN 50% OF SUBJECTS OF PROPHYLACTIC NOREPINEPHRINE INFUSIONS FOR PREVENTING SPINAL ANESTHESIA-INDUCED HYPOTENSION DURING CESAREAN DELIVERY Ondansetron 4 MG, 0.9% Saline - Hypotension, Anesthesia; Adverse Effect, Spinal and Epidural | Phase 3 | Unknown | Laval University | 60 | 2021-06-01 | 2021-01-12 |
| Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP Ondansetron 4 mg, Palonosetron 75 mcg - Antiemetic, Postoperative Nausea and Vomiting | Phase 4 | Unknown | Theodor Bilharz Research Institute | 90 | 2020-10-24 | 2020-10-06 |
| Chewing Gum to Prevent Nausea and Vomiting After Caesarean Section Under Spinal Anaesthesia Chewing Gum, Ondansetron 4 MG - PONV | Not applicable | Unknown | Coombe Women and Infants University Hospital | 284 | 2019-10-28 | 2020-01-23 |
| Anti-shivering Effect of Ondansetron Normal saline, Ondansetron 4 MG, Ondansetron 8mg - Shivering, Ondansetron | Phase 2 / Phase 3 | Unknown | Assiut University | 120 | 2018-05-15 | 2018-05-21 |
| Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting Ondansetron 4 MG, Ondansetron 8mg - Post-operative Nausea and Vomiting | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 141 | 2017-10-23 | 2020-07-20 |
| PECS-2 for Breast Surgery Ropivacaine 5 mg/ml, 35 ml, Remifentanil 50 microg/ml, Betamethason 4 mg - Breast Neoplasm Female, Regional Anesthesia | Not applicable | Completed | Umeå University | 200 | 2017-05-23 | 2021-06-04 |
| Efficacy of Ondansetron in LARS Treatment Ondansetron 4 MG, Placebo - Rectal Cancer | Not applicable | Completed | Ente Ospedaliero Cantonale, Bellinzona | 48 | 2016-11-01 | 2022-10-17 |
| Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting aprepitant 40 mg, ondansetron 4 mg - Postoperative Nausea and Vomiting | Not applicable | Withdrawn | Northwell Health | 2008-06-01 | 2013-08-12 |
Postoperative Nausea and Vomiting (5) · Vomiting (3) · Hypotension (2) · Anxiety Disorders (1) · Nausea (1) · Rectal Neoplasms (1)
Ain Shams University (1) · Assiut University (1) · Cairo University (1) · Coombe Women and Infants University Hospital (1) · Ente Ospedaliero Cantonale, Bellinzona (1) · Faisalabad Medical University (1) · General Hospital of Ningxia Medical University (1) · Icahn School of Medicine at Mount Sinai (1) · Jennifer Holder-Murray (1) · Laval University (1) · Lizar Aguirre Pascasio (1) · Menoufia University (1) · Montefiore Medical Center (1) · Northwell Health (1) · Northwestern University (1)
United States (5) · Egypt (3) · China (1) · Ireland (1) · Pakistan (1) · Sweden (1) · Switzerland (1)
Angela Maeder, PhD (1) · Asifa Saeed, MBBS; FCPS (1) · Azza Barmoud Nashed Kassab, PhD (1) · Benjamin W Friedman, MD MS (1) · Christopher Choi, DDS (1) · Daniel Katz, MD (1) · Dimitri Christoforidis, Prof. (1) · Joakim Johansson, PhD (1) · Omar M. Abou-Hashim, residant (1) · Stephen Esper, MD, MBA (1) · Terry Tan (1) · Yahia M. Hammad, Lecteurer (1) · Yi Chen, M.D. (1)